September 25, 2017 10:28 AM ET

Pharmaceuticals

Company Overview of Daiichi-Sankyo Pharma Development, Inc

Company Overview

Daiichi-Sankyo Pharma Development, Inc engages in the development of drugs and therapeutic agents for Cardiovascular, Diabetes, Infection, Immunology, Oncology, and Bone and joint diseases. The company also provides research and development services. The major products of the company includes pactimibe and ARQ 197. The company is based in Edison, New Jersey. Daiichi-Sankyo Pharma Development, Inc operates as a subsidiary of Daiichi Sankyo, Inc.

399 Thornall Street

Edison, NJ 08837

United States

Phone:

732-590-5000

Fax:

732-906-5690

Key Executives for Daiichi-Sankyo Pharma Development, Inc

President and Chief Science Officer
Executive Vice President of Drug Development for Americas Region
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Daiichi-Sankyo Pharma Development, Inc, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.